Study highlights benefits and risks of doxy-PEP for STI prevention

Taking a dose of the oral antibiotic doxycycline after a high-risk sexual encounter has dramatically reduced the incidence of sexually transmitted infections (STIs) in places where the strategy is being tried.

Greenlane Q1 Revenue Lifts 9% Sequentially

Greenlane Reports Q1 2023 Revenue Increase of 9% and a 32% Decrease in Operating Expenses Over Q4 2022 BOCA RATON, FL / ACCESSWIRE / May

May 16, 2023

Drug aimed at strengthening neurons to treat Alzheimer’s fails in trial

A dark horse effort to treat Alzheimer’s disease, already marred by a data manipulation scandal, fell short in a randomized trial reported Tuesday afternoon. Athira

September 3, 2024

Using edible fungi to create sustainable systems for food production

What makes people interested in fungi-based food as an alternative to other protein sources such as meat? A new doctoral thesis explains how it is

June 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.